International Journal of Oncology

REGIONAL LOSS OF THE Y-CHROMOSOME IN UROTHELIAL CARCINOMA
pp. 115-119(5)
Authors: LUTZ, S; WELTER, C; URBSCHAT, K; SEITZ, G; BLIN, N

PROLIFERATIVE ACTIVITY OF CARCINOMA OF THE PAPILLA OF VATER - AN IMMUNOHISTOCHEMICAL STUDY DEMONSTRATING PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA)
pp. 121-124(4)
Authors: MORI, K; NAGAKAWA, T; OHTA, T; NAKANO, T; KAYAHARA, M; KANNO, M; UENO, K; MIYAZAKI, I; TERADA, T; NAKANUMA, Y

DETECTION OF HEPATITIS-B VIRUS-DNA AT HIGH-FREQUENCY IN LIVER NEOPLASIAS USING A PCR TECHNIQUE
pp. 125-128(4)
Authors: HALIASSOS, A; ARVANITIS, D; PARLIARAS, J; SPANDIDOS, DA

SYNERGISTIC POTENTIATION OF CISPLATIN CYTOTOXICITY BY CAFFEINE IN A CISPLATIN-RESISTANT RAT OVARIAN TUMOR-CELL LINE
pp. 129-134(6)
Authors: CHEN, G; ZELLER, WJ

FURTHER CHARACTERIZATION OF ACQUIRED-RESISTANCE TO CISPLATIN IN A RAT OVARIAN TUMOR-CELL LINE
pp. 135-140(6)
Authors: CHEN, G; HUTTER, KJ; ZELLER, WJ

SIMPLE AND EFFICIENT CHEMOSENSITIVITY ASSAY FOR HUMAN PRIMARY TUMOR-CELLS USING CONTACT-SENSITIVE MICROTITER PLATES
pp. 141-147(7)
Authors: MITSUGI, K; NAKANO, S; NAKAYAMA, M; ICHINOSE, I; ANZAI, K; KUROKI, M; NAKAMURA, M; NAGAFUCHI, S; NIHO, Y

DIFFERENTIAL SPLICING OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN THE RAT - SPLICE VARIANTS HOMOLOGOUS WITH THE HUMAN ARE EXPRESSED IN RAT-CELLS
pp. 149-152(4)
Authors: KYRITSIS, AP; LEE, PSY; MOCHIZUKI, H; NISHI, T; LEVIN, VA; SAYA, H

PROGNOSTIC FACTORS IN BREAST-CANCER (REVIEW)
pp. 153-159(7)
Authors: AALTOMAA, S; LIPPONEN, P

AMPHIBIAN TISSUE REGENERATION - A MODEL FOR CANCER REGULATION (REVIEW)
pp. 161-164(4)
Authors: DELRIOTSONIS, K; TSONIS, PA

SYNERGY OF INTERLEUKIN-5 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
pp. 165-174(10)
Authors: AOKI, T; KIKUCHI, H; MIYATAKE, SI; ODA, Y; OTSUKA, SI; KINASHI, T; HONJO, T

BINDING OF TRANSCRIPTION FACTOR SP1 TO EXON-1 OF C-MYC IS ALTERED IN BURKITTS-LYMPHOMA
pp. 175-180(6)
Authors: BRYANS, M; LUCAS, JM; WILKIE, NM; BURROW, K; CLARK, AM; LANG, JC

SUBCUTANEOUS RIL-2 IN ADVANCED MELANOMA AND KIDNEY CARCINOMA
pp. 181-189(9)
Authors: DELENA, M; GUIDA, M; CASAMASSIMA, A; ADDABBO, L; ABBATE, I; CORREALE, M; MUSCI, MD; LORUSSO, V; LATORRE, A; MASTRIA, A

DIFFERENCES IN THE TUMOR DNA ANALYSIS OF A HEPATOCELLULAR-CARCINOMA AND A SYNCHRONOUS FIBROLAMELLAR VARIANT
pp. 191-193(3)
Authors: DING, SF; WONG, K; DAVIDSON, B; DOOLEY, J; DHILLON, AP; WOOD, CB; HABIB, NA

METHODOLOGICAL ASPECTS OF PHASE-I STUDIES OF NOVEL ANTICANCER AGENTS (REVIEW)
pp. 195-199(5)
Authors: CASSIDY, J; BISSETT, D; KERR, D

CLONAL EVOLUTION AND TUMOR PROGRESSION IN 2 HUMAN COLORECTAL ADENOMA-DERIVED CELL-LINES INVITRO - THE INVOLVEMENT OF CHROMOSOME-1 ABNORMALITIES
pp. 201-208(8)
Authors: HAGUE, A; HANLON, KA; PARASKEVA, C

HUMAN AND RODENT FIBROBLASTS - MODEL SYSTEMS FOR STUDYING SENESCENCE AND IMMORTALIZATION (REVIEW)
pp. 209-213(5)
Authors: GONOS, ES; POWELL, AJ; JAT, PS

MUTATIONS IN AN ALTERNATIVELY SPLICED EXON OF H-RAS ARE NOT ASSOCIATED WITH LOSS OF HETEROZYGOSITY ON CHROMOSOME 11P15.5 IN OVARIAN TUMORIGENESIS
pp. 215-219(5)
Authors: FRIEDMAN, RL; VELICESCU, M; DUBEAU, L

CONSTITUTIVE EXPRESSION OF C-MYC IN NIH 3T3 CELLS WHICH COEXPRESS THE COLONY STIMULATING FACTOR-I RECEPTOR AND THE CATALYTIC DOMAIN OF THE GTPASE-ACTIVATING PROTEIN RESTORES COLONY STIMULATING FACTOR-I DEPENDENT MITOGENIC GROWTH
pp. 221-225(5)
Authors: BORTNER, DM; ULIVI, M; OSTROWSKI, MC

FLUDARABINE PHOSPHATE SELECTIVELY INHIBITS GROWTH AND MODIFIES THE ANTIGENIC PHENOTYPE OF HUMAN GLIOBLASTOMA-MULTIFORME CELLS EXPRESSING A MULTIDRUG RESISTANCE PHENOTYPE
pp. 227-239(13)
Authors: JIANG, HP; SU, ZZ; DATTA, S; GUARINI, L; WAXMAN, S; FISHER, PB